openPR Logo
Press release

No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support

07-21-2025 07:40 PM CET | Politics, Law & Society

Press release from: ABNewswire

HAUTUKI GROWTH SUPPORT PATCH

HAUTUKI GROWTH SUPPORT PATCH

Korean patch Hautuki ends supplement battles. Kids manage growth support independently through bedtime application. Unlike oral supplements 60% resist, transdermal system delivers nutrients through skin over 8-10 hours. Emma Chen, 9, went from hiding at vitamin time to proudly applying patches. "Now it's drama-free," says Hong Kong mother.
HONG KONG - Every evening at 8 PM, 9-year-old Emma Chen used to hide in her bedroom, dreading the nightly battle with her mother over growth vitamins. The familiar scene played out in households across Asia: tears, negotiations, and ultimately, a frustrated parent watching their child reluctantly swallow yet another pill.

Today, Emma looks forward to bedtime. She proudly applies a small patch near her arm - a routine she now manages entirely on her own. "I don't have to taste anything yucky anymore," she explains, while her mother watches with visible relief.

Emma's transformation represents a growing trend among families discovering Hautuki [https://hautuki.hk/products/hautuki-growth-support-patch], a Korean-developed patch-based growth support system that's quietly revolutionizing how children approach their health routines.

Image: https://www.abnewswire.com/upload/2025/07/7afdd8c9547a2d767c0b5b0d17072346.jpg

Nine-year-old Emma applies her Hautuki patch independently before bedtime - a routine she now manages entirely on her own.

The Daily Battle Millions of Parents Know Too Well

For parents concerned about their child's growth, the statistics paint a challenging picture. Industry research suggests that up to 60% of children regularly resist taking oral supplements, creating a cycle of stress that often defeats the purpose of growth support entirely.

"We were spending more energy fighting about vitamins than actually helping our child grow," says Jennifer Wong, a Hong Kong mother of two.

Online parent forums are filled with similar stories: children who gag at the sight of pills, families who've tried every flavored vitamin on the market, and parents who eventually give up on supplementation altogether.

When Kids Take Control

The breakthrough came when Custics Corporation, a Seoul-based biotechnology company, asked a different question: instead of making supplements easier for parents to give, what if children could manage their growth routine independently?

Their answer was Hautuki [https://hautuki.hk/products/hautuki-growth-support-patch] - a transdermal patch that delivers nutrients through the skin, eliminating the need for swallowing, tasting, or parental intervention.

"When children feel ownership over their health choices, compliance becomes natural rather than forced," explains Dr. Sarah Kim, a pediatric nutritionist who has observed the product's impact.

The technology works through controlled absorption via the skin, bypassing the digestive system entirely. Children simply apply one patch before bedtime - a process most can master independently within days.

Image: https://www.abnewswire.com/upload/2025/07/0273ce8c6bfec40e4c0b74a0716c09f4.jpg [https://hautuki.hk/]

The Science of Consistency

Traditional oral supplements face what researchers call the "compliance gap" - the difference between prescribed and actual intake. Even motivated families struggle to maintain perfect supplement routines, with missed doses occurring an average of 2-3 times per week.

Hautuki's transdermal delivery system provides steady nutrient absorption over 8-10 hours, creating more consistent blood levels than traditional oral supplements that create peaks and valleys in nutrient availability.

"The patch doesn't just solve the compliance problem," notes Dr. Michael Chang, a Hong Kong pediatrician. "It actually provides more stable nutrient delivery than oral supplements, even when those are taken perfectly."

A Regional Success Story

Since launching in South Korea, Hautuki has expanded across major Asian markets, with Hong Kong representing one of its fastest-growing segments. Local distributors report that word-of-mouth referrals drive much of the product's growth.

"Asian parents have always been proactive about their children's growth, but they're increasingly looking for solutions that reduce family stress while maintaining effectiveness," says wellness industry analyst Lisa Park. "Hautuki [https://hautuki.hk/products/hautuki-growth-support-patch]hits both targets."

Changing the Conversation

Perhaps most significantly, Hautuki is changing how families talk about growth support. Instead of viewing supplementation as something imposed by parents, children increasingly see it as a personal routine they can manage independently.

"My daughter actually reminds me when it's time to reorder patches," laughs Maria Santos, a Hong Kong expatriate mother. "She's taken complete ownership of her growth routine."

Child psychologists note that when children successfully manage health routines on their own, it builds confidence and establishes positive patterns for lifelong self-care.

The Future of Family Health

As Hautuki [https://hautuki.hk/] continues its expansion across Asia, industry observers are watching whether its success signals broader changes in pediatric health products. The emphasis on child autonomy and stress reduction represents a departure from traditional approaches.

"We're seeing the emergence of 'child-centric' health products," explains healthcare innovation researcher Dr. James Liu. "Companies are asking how to make children more effective at managing their own health."

For families like the Chens, the change has been transformative. Emma now views her nightly patch application as a sign of growing up, not a medical chore.

"Growth support used to be about pills, schedules, and arguments," reflects Jennifer Wong. "Now it's just part of life - simple, effective, and completely drama-free."

As more families discover patch-based solutions, the days of supplement struggles may soon become a thing of the past, replaced by a new generation of children who approach their health with confidence and independence.

Media Contact
Company Name: Glovertise
Contact Person: Erick
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=no-more-pills-no-more-struggles-korean-innovation-transforms-how-kids-approach-growth-support]
Phone: 01091916367
Address:7/F TOWER 2 SOUTH SEAS CTR 75 MODY RD #706
City: HONG KONG
State: TSIM SHA TSUI
Country: HongKong
Website: https://hautuki.hk

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support here

News-ID: 4112760 • Views:

More Releases from ABNewswire

CopperJoint x Paulina Jayne: The Official Launch of the Pink Sock Collection, Celebrating Movement, Joy, and Everyday Confidence
CopperJoint x Paulina Jayne: The Official Launch of the Pink Sock Collection, Ce …
CopperJoint proudly announces the nationwide release of its new Pink Sock Collection, a movement-inspired collaboration with Nashville singer-songwriter Paulina Jayne. Combining expressive style with meaningful daily motivation, the long pink compression socks feature two signature woven message bands - "KEEP GOING" and "JOY IN MOTION." This collection marks an exciting moment for women that not only looks good, but also lifts the spirit. An Inspired Partnership with Purpose The collaboration began with
TCL Offers Unmatched Discounts on NXTPAPER 11 Gen 2 Tablets for a Limited Time
TCL Offers Unmatched Discounts on NXTPAPER 11 Gen 2 Tablets for a Limited Time
Image: https://www.abnewswire.com/upload/2025/11/7d28d258c990d6d6d333a09d1195a4d9.jpg TCL is making eye comfort more affordable than ever this Black Friday, with both configurations of its NXTPAPER 11 Gen 2 tablet [https://www.amazon.com/dp/B0FG7FRDPL?maas=maas_adg_F465400792B3CDBEB55FE9291F5841A8_afap_abs&ref_=aa_maas&tag=maas] seeing record-low prices on Amazon. From now through December 1, the 64 GB version is down to $159.99 (36% off), and the 128 GB version is just $179.99 (38% off). The NXTPAPER 11 Gen 2 stands out for its paper-like 11-inch Full HD+ display, powered by TCL's
TCL offers exceptional deal making NXTPAPER 11 Plus tablet affordable under 300$
TCL offers exceptional deal making NXTPAPER 11 Plus tablet affordable under 300$
If you're looking for a tablet that balances performance, comfort, and value, the NXTPAPER 11 Plus from TCL [https://www.amazon.com/dp/B0FLJMFNR7?maas=maas_adg_5AF2681E26EC62C74DF5C1C72CE6A9DD_afap_abs&ref_=aa_maas&tag=maas] is shaping up to be one of this year's smartest buys. With the Black Friday sale underway, you can snag it for just $249.99. Image: https://www.abnewswire.com/upload/2025/11/da5f5868666d07b1b589c9593af7a59f.jpg The 11.5" 2.2K resolution screen uses TCL's proprietary NXTPAPER 4.0 technology, designed to reduce glare, cut blue-light emission, and deliver a more "paper-like" reading experience - ideal
TCL Unveils Exceptional Offer on the Advanced NXTPAPER 11 Gen 2 Tablet
TCL Unveils Exceptional Offer on the Advanced NXTPAPER 11 Gen 2 Tablet
If you're on the lookout for an affordable tablet this Black Friday that's easy on the eyes, the TCL NXTPAPER 11 Gen 2 (128 GB) [https://www.amazon.com/dp/B0FG7QV6SF?maas=maas_adg_1486FCD4C758EA9A35182092D196F846_afap_abs&ref_=aa_maas&tag=maas] is now a serious contender - and with its current deal, it's one to watch. Image: https://www.abnewswire.com/upload/2025/11/1c870dfdbb5765161f68d40f15583e4c.jpg Original price: $289.99 Black Friday price: $179.99 - that's 38% off (about $110 off) Deal runs from November 20 through December 1, 2025, available on Amazon. Eye-friendly NXTPAPER display: The NXTPAPER 4.0

All 5 Releases


More Releases for Hautuki

Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study
Hautuki Clinically Proven to Support Height Growth and Ensure Safety Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year. Image: https://www.abnewswire.com/upload/2025/05/75daaface7cea909f35fd494150fea0f.PNG The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12. After eight weeks, the group that used the Hautuki patch
CUSTICS SINGAPORE's Growth Nutrient Patch 'Hautuki' Completes Clinical Study
Image: https://www.abnewswire.com/upload/2025/01/d0c11fb6ef950d96ffc92b987934691b.jpg CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as "CUSTICS SINGAPORE [https://hautuki.sg/]") has successfully completed clinical study on its 'Hautuki [https://hautuki.sg/]' growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability. From January to November 2024, the study
Hautuki, A Globally Recognized Innovative Patch Type Nutrition Solution for Chil …
Hautuki, an innovative children's nutrition product manufactured in South Korea, is gaining global recognition. Exported to countries including the United States, Singapore, Hong Kong, Taiwan, Malaysia, Indonesia, China, and the Philippines, Hautuki has established itself as a trusted brand in international markets. CUSTICS, the company behind Hautuki, operates legal entities in South Korea, Singapore, Taiwan, and Hong Kong, strengthening its global presence. Based on its vision to "shine and illuminate," CUSTICS
HAUTUKI Innovates Efficient Vitamin D Delivery for Children through Transdermal …
Recent nutritional surveys conducted both domestically and internationally indicate that more than 80% of children in their growth phase suffer from vitamin D deficiency or insufficiency. Research also shows that children with stunted growth are more prone to vitamin D deficiency compared to their peers. In countries with frequent rainy or overcast days, ensuring adequate vitamin D intake is naturally more challenging. Image: https://www.abnewswire.com/uploads/d2d7d3db97fca5f29490d3971d5e13d5.jpg CUSTICS Inc. (CEO LEE KANG IL), in their
Custics Singapore's HAUTUKI Secures FDA OTC Product Registration and Excels in S …
Custics Singapore announces that HAUTUKI has achieved a significant milestone by securing registration as an OTC Product with the U.S. FDA HAUTUKI, a cutting-edge product developed through technology transferred from Seoul National University, integrates a unique blend of vitamins and nutrients designed to amplify its effectiveness. At the core of HAUTUKI's innovation is a patented peptide ligand from the Department of Biotechnology at Seoul National University. This advanced technology is engineered
CUSTICS Launches Hautuki as an OTC Product in Singapore
CUSTICS SINGAPORE PTE. LTD. has announced that its product, Hautuki, has already completed registration with the U.S. FDA Administration OTC Product. According to a company representative, Hautuki was developed by CUSTICS Co., Ltd. using TDDS technology previously acquired from Seoul National University. This innovative patch integrates vitamins and various nutrients and is specifically designed to support children's growth. Image: https://www.abnewswire.com/uploads/85ea01f2e25cff2bd5d8e29463a3d6d2.png The technology is the "Pore-Permeable Transdermal Peptide Ligand," a patented innovation from the